These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 37058588)

  • 1. MF-PCBA: Multifidelity High-Throughput Screening Benchmarks for Drug Discovery and Machine Learning.
    Buterez D; Janet JP; Kiddle SJ; Liò P
    J Chem Inf Model; 2023 May; 63(9):2667-2678. PubMed ID: 37058588
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changing the HTS Paradigm: AI-Driven Iterative Screening for Hit Finding.
    Dreiman GHS; Bictash M; Fish PV; Griffin L; Svensson F
    SLAS Discov; 2021 Feb; 26(2):257-262. PubMed ID: 32808550
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Using information from historical high-throughput screens to predict active compounds.
    Riniker S; Wang Y; Jenkins JL; Landrum GA
    J Chem Inf Model; 2014 Jul; 54(7):1880-91. PubMed ID: 24933016
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LIT-PCBA: An Unbiased Data Set for Machine Learning and Virtual Screening.
    Tran-Nguyen VK; Jacquemard C; Rognan D
    J Chem Inf Model; 2020 Sep; 60(9):4263-4273. PubMed ID: 32282202
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Formalization, annotation and analysis of diverse drug and probe screening assay datasets using the BioAssay Ontology (BAO).
    Vempati UD; Przydzial MJ; Chung C; Abeyruwan S; Mir A; Sakurai K; Visser U; Lemmon VP; Schürer SC
    PLoS One; 2012; 7(11):e49198. PubMed ID: 23155465
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bambu and its applications in the discovery of active molecules against melanoma.
    Guidotti IL; Neis A; Martinez DP; Seixas FK; Machado K; Kremer FS
    J Mol Graph Model; 2023 Nov; 124():108564. PubMed ID: 37453311
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Using the BioAssay Ontology for analyzing high-throughput screening data.
    Zander Balderud L; Murray D; Larsson N; Vempati U; Schürer SC; Bjäreland M; Engkvist O
    J Biomol Screen; 2015 Mar; 20(3):402-15. PubMed ID: 25512330
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Learning-to-rank technique based on ignoring meaningless ranking orders between compounds.
    Ohue M; Suzuki SD; Akiyama Y
    J Mol Graph Model; 2019 Nov; 92():192-200. PubMed ID: 31377536
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DRABAL: novel method to mine large high-throughput screening assays using Bayesian active learning.
    Soufan O; Ba-Alawi W; Afeef M; Essack M; Kalnis P; Bajic VB
    J Cheminform; 2016; 8():64. PubMed ID: 27895719
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systematic error detection in experimental high-throughput screening.
    Dragiev P; Nadon R; Makarenkov V
    BMC Bioinformatics; 2011 Jan; 12():25. PubMed ID: 21247425
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Open access high throughput drug discovery in the public domain: a Mount Everest in the making.
    Roy A; McDonald PR; Sittampalam S; Chaguturu R
    Curr Pharm Biotechnol; 2010 Nov; 11(7):764-78. PubMed ID: 20809896
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Computational Analysis and In silico Predictive Modeling for Inhibitors of PhoP Regulon in S. typhi on High-Throughput Screening Bioassay Dataset.
    Kaur H; Ahmad M; Scaria V
    Interdiscip Sci; 2016 Mar; 8(1):95-101. PubMed ID: 26298582
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Scopy: an integrated negative design python library for desirable HTS/VS database design.
    Yang ZY; Yang ZJ; Lu AP; Hou TJ; Cao DS
    Brief Bioinform; 2021 May; 22(3):. PubMed ID: 32892221
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ARQiv-HTS, a versatile whole-organism screening platform enabling in vivo drug discovery at high-throughput rates.
    White DT; Eroglu AU; Wang G; Zhang L; Sengupta S; Ding D; Rajpurohit SK; Walker SL; Ji H; Qian J; Mumm JS
    Nat Protoc; 2016 Dec; 11(12):2432-2453. PubMed ID: 27831568
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nuisance Compounds, PAINS Filters, and Dark Chemical Matter in the GSK HTS Collection.
    Chakravorty SJ; Chan J; Greenwood MN; Popa-Burke I; Remlinger KS; Pickett SD; Green DVS; Fillmore MC; Dean TW; Luengo JI; Macarrón R
    SLAS Discov; 2018 Jul; 23(6):532-545. PubMed ID: 29699447
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genomic benchmarks: a collection of datasets for genomic sequence classification.
    Grešová K; Martinek V; Čechák D; Šimeček P; Alexiou P
    BMC Genom Data; 2023 May; 24(1):25. PubMed ID: 37127596
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Data-driven approaches used for compound library design, hit triage and bioactivity modeling in high-throughput screening.
    Paricharak S; Méndez-Lucio O; Chavan Ravindranath A; Bender A; IJzerman AP; van Westen GJP
    Brief Bioinform; 2018 Mar; 19(2):277-285. PubMed ID: 27789427
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Public Domain HTS Fingerprints: Design and Evaluation of Compound Bioactivity Profiles from PubChem's Bioassay Repository.
    Helal KY; Maciejewski M; Gregori-Puigjané E; Glick M; Wassermann AM
    J Chem Inf Model; 2016 Feb; 56(2):390-8. PubMed ID: 26898267
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimal HTS Fingerprint Definitions by Using a Desirability Function and a Genetic Algorithm.
    Cortes Cabrera A; Petrone PM
    J Chem Inf Model; 2018 Mar; 58(3):641-646. PubMed ID: 29425455
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Data-Driven Derivation of an "Informer Compound Set" for Improved Selection of Active Compounds in High-Throughput Screening.
    Paricharak S; IJzerman AP; Jenkins JL; Bender A; Nigsch F
    J Chem Inf Model; 2016 Sep; 56(9):1622-30. PubMed ID: 27487177
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.